Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Inhibition of human N- and T-type calcium channels by an ortho-phenoxyanilide derivative, MONIRO-1.

McArthur JR, Motin L, Gleeson EC, Spiller S, Lewis RJ, Duggan PJ, Tuck KL, Adams DJ.

Br J Pharmacol. 2017 Jun 13. doi: 10.1111/bph.13910. [Epub ahead of print]

PMID:
28608537
2.

Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA1c and fasting plasma glucose.

Spiller S, Li Y, Bl├╝her M, Welch L, Hoffmann R.

Clin Proteomics. 2017 Mar 28;14:10. doi: 10.1186/s12014-017-9145-1. eCollection 2017.

3.

Quantification of specific glycation sites in human serum albumin as prospective type 2 diabetes mellitus biomarkers.

Spiller S, Frolov A, Hoffmann R.

Protein Pept Lett. 2017 Feb 2. doi: 10.2174/0929866524666170202124120. [Epub ahead of print]

PMID:
28155619
4.

Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives.

Gleeson EC, Graham JE, Spiller S, Vetter I, Lewis RJ, Duggan PJ, Tuck KL.

Mar Drugs. 2015 Apr 13;13(4):2030-45. doi: 10.3390/md13042030.

5.

Arginine-derived advanced glycation end products generated in peptide-glucose mixtures during boiling.

Frolov A, Schmidt R, Spiller S, Greifenhagen U, Hoffmann R.

J Agric Food Chem. 2014 Apr 23;62(16):3626-35. doi: 10.1021/jf4050183. Epub 2014 Apr 11.

PMID:
24725187

Supplemental Content

Loading ...
Support Center